高级检索
当前位置: 首页 > 详情页

Arsenic up-regulates PD-L1 and enhances lung tumorigenesis through activation of STAT3 in alveolar epithelial type 2 cells

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Univ Kentucky, Coll Med, Dept Pharmacol & Nutr Sci, Lexington, KY 40536 USA [2]Univ Sci & Technol China, Dept Urol, Affiliated Hosp 1, Hefei 230001, Anhui, Peoples R China [3]Yichun Univ, Coll Med, Dept Biochem, Yichun 336000, Jiangxi, Peoples R China [4]First Peoples Hosp Yunnan Prov, Dept Gen Med, Kunming 650032, Yunnan, Peoples R China [5]Univ Kentucky, Coll Med, Dept Pharmacol & Nutr Sci, MN306,UKMC,800 Rose St, Lexington, KY 40536 USA
出处:
ISSN:

关键词: Arsenic Mice Lung Tumor Tumorigenesis STAT3 PD-L1

摘要:
Arsenic is a carcinogen and chronic exposure to arsenic increases the risk of many cancers, including lung cancer. However, the underlying mechanism is not clear. Using A/J mice as a model, our previous animal study has shown that chronic arsenic exposure up-regulates PD-L1 on lung tumor cells which interacts with PD-1 on T cells and inhibits T cell anti-tumor function resulting in increased lung tumorigenesis. In a subsequent in vitro study, we further found that arsenic up-regulated PD-L1 by activating STAT3 at tyrosine 705 in lung epithelial cells, and inhibition of STAT3 mitigated arsenic-induced PD-L1 up-regulation. The present study aims to determine whether STAT3 regulates PD-L1 in the lung of A/J mice and the type of cells from which lung tumor develops upon arsenic exposure. For that purpose, a mouse line with STAT3 conditional knockout in alveolar type 2 (AT2) cells was developed. Our results indicate that arsenic exposure up-regulates PD-L1 in AT2 cells through acti-vating STAT3 in A/J mice. Conditional knockout of STAT3 in AT2 cells inhibited arsenic-induced PD-L1 up-regulation and lung tumor formation. Thus, our findings reveal that STAT3 is the upstream regulator of arsenic-induced PD-L1 up-regulation in AT2 cells and the inhibition of T cell anti-tumor function in the lung, and that AT2 cells are sensitive to arsenic exposure and from which arsenic-enhanced lung tumor formation in A/J mice.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2025]版:
大类 | 3 区 医学
小类 | 2 区 毒理学 3 区 药学
最新[2025]版:
大类 | 3 区 医学
小类 | 2 区 毒理学 3 区 药学
JCR分区:
出版当年[2023]版:
Q2 PHARMACOLOGY & PHARMACY Q2 TOXICOLOGY
最新[2023]版:
Q2 PHARMACOLOGY & PHARMACY Q2 TOXICOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2023版] 出版当年五年平均 出版前一年[2022版]

第一作者:
第一作者机构: [1]Univ Kentucky, Coll Med, Dept Pharmacol & Nutr Sci, Lexington, KY 40536 USA [2]Univ Sci & Technol China, Dept Urol, Affiliated Hosp 1, Hefei 230001, Anhui, Peoples R China
通讯作者:
通讯机构: [1]Univ Kentucky, Coll Med, Dept Pharmacol & Nutr Sci, Lexington, KY 40536 USA [5]Univ Kentucky, Coll Med, Dept Pharmacol & Nutr Sci, MN306,UKMC,800 Rose St, Lexington, KY 40536 USA
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:87470 今日访问量:0 总访问量:721 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西山区金碧路157号